⏳
Showing Q1 2025 data
Aquilo Capital Management, LLC's Q4 2025 filing not yet available. Expected by Feb 14, 2026.
Aquilo Capital Management, LLC
•CIK: 1591986•Filing: Q1 2025
**Aquilo Capital Management, LLC** is a focused investment manager overseeing $56M in assets. The fund maintains a concentrated portfolio of 13 positions, with significant allocations to biotechnology and healthcare names. Top holdings include AMGN at $18.7M, followed by 2L9 ($7.4M) and ARWR ($7.0M). This structure suggests a deep-value, sector-specific approach within the life sciences space.
Total AUM
$37.1M
+ $18.7M in options
QoQ Performance
-36.5%
Positions
12
+ 1 option
Top 10 Concentration
93.4%
Latest Filing
Q1 2025
Top Holdings Allocation
AMGN
2L9
ARWR
PTGX
KYMR
DTIL
AMGN33.5%
2L913.3%
ARWR12.6%
PTGX7.1%
KYMR6.8%
DTIL6.2%
ARVN4.5%
RGNX3.5%
📈 Biggest Buys
📉 Biggest Sells
Sector Breakdown
Other66.5%
Healthcare33.5%
🚪 Exited Positionssold since Q4 2024
—
SUTRO BIOPHARMA INC
SOLD
$916
Changes from Q4 2024
NEW1 new position
↑4 increased
↓7 decreased
Historical Filings
Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023